Management of Severe Hypotension

Initial Resuscitation

The American College of Critical Care Medicine recommends initiating fluid resuscitation with crystalloids (250-500 mL bolus) while starting norepinephrine as the first-line vasopressor, targeting a mean arterial pressure of 65 mmHg in patients with severe hypotension 1, 2
The Surviving Sepsis Campaign suggests that norepinephrine is the first-choice vasopressor with Grade 1B evidence 2
The initial norepinephrine dosing is 8-12 mcg/minute (2-3 mL/minute of diluted solution), titrated to effect 3

Administer an initial crystalloid bolus of 250-500 mL in adults (or 10-20 mL/kg in children) using normal saline or balanced crystalloid solution 1, 4
Use the passive leg raise (PLR) test to determine fluid responsiveness before additional boluses, as it has a positive likelihood ratio of 11 and 92% specificity 1, 5

Start norepinephrine immediately if fluid resuscitation alone does not achieve target MAP of 65 mmHg 2, 1
Add vasopressin (0.03 U/min) as a second-line agent if increasing doses of norepinephrine are required 2, 1
Consider epinephrine (0.05-0.5 mcg/kg/min) as third-line therapy for refractory hypotension 2, 3

Target a mean arterial pressure (MAP) of 65 mmHg as the initial resuscitation goal 2, 6, 7
Maintain MAP ≥80 mmHg to ensure adequate cerebral perfusion in patients with traumatic brain injury 1, 5
Use permissive hypotension targeting systolic BP 80-90 mmHg until bleeding is controlled in patients with uncontrolled hemorrhage without brain injury 4, 8, 1

If anaphylaxis is suspected, administer epinephrine 0.3-0.5 mg (0.01 mg/kg in children, max 0.3 mg) intramuscularly into the deltoid or lateral thigh immediately, repeating every 5 minutes as necessary 9, 10
If cardiogenic shock is suspected, start dobutamine at 2-5 mcg/kg/min (without bolus) for low cardiac output states, while maintaining blood pressure with norepinephrine 2, 3
If hemorrhagic shock is present, use restricted volume replacement strategy targeting systolic BP 80-90 mmHg until surgical hemorrhage control is achieved (unless traumatic brain injury is present) 4, 8, 1
If adrenal crisis is suspected, administer hydrocortisone 100 mg IV bolus immediately, followed by 50 mg IV every 6 hours or 200 mg continuous infusion 6

Establish continuous monitoring including invasive arterial blood pressure monitoring, central venous access, continuous ECG monitoring, urine output, serial lactate measurements, and frequent reassessment of mental status, skin perfusion, and capillary refill 1, 7, 2, 3

Never delay vasopressor initiation while pursuing aggressive fluid resuscitation in patients with severe hypotension (MAP <50 mmHg), as this increases mortality 4, 2
Avoid phenylephrine as first-line therapy except when tachycardia is present, as reflex bradycardia can worsen cardiac output 1, 3
Do not use permissive hypotension in traumatic brain injury patients, as cerebral perfusion pressure must be maintained 1, 5
Avoid vasodilators and diuretics when systolic BP <90 mmHg, as this worsens outcomes 3
Do not administer additional fluid boluses in patients with signs of volume overload (pulmonary edema, elevated JVP) without reassessing fluid responsiveness 1, 3
Avoid intravenous epinephrine except in cardiac arrest or profound hypotension unresponsive to multiple doses of intramuscular epinephrine and norepinephrine, due to risk of lethal arrhythmias 9, 10

Discontinue the IV oxytocin infusion immediately when hypotension develops in obstetric patients. 11
Position the patient in a lateral decubitus (or Trendelenburg) posture to improve venous return and attenuate hemodynamic instability. 11

Give a rapid crystalloid bolus of 250–500 mL (normal saline or balanced solution) over 30–60 minutes to restore intravascular volume. 12
Re‑measure blood pressure 30 minutes after the initial bolus; if hypotension persists, administer an additional 250 mL crystalloid bolus. 12

If blood pressure remains low after adequate fluid resuscitation, start phenylephrine at 0.1 µg/kg/min (or norepinephrine) and titrate to a mean arterial pressure ≥ 65 mmHg. 13

Provide continuous arterial blood pressure monitoring (arterial line if severe or refractory) and heart‑rate surveillance. 11
Monitor oxygen saturation continuously and watch for pulmonary edema resulting from fluid shifts and oxytocin’s antidiuretic effect. 13

Administer oxytocin as a slow IV infusion at < 2 U/min rather than as a rapid bolus to avoid systemic hypotension. 11

Methylergonovine is absolutely contraindicated in the setting of oxytocin‑induced hypotension because it can cause severe hypertension. 11
Prostaglandin F analogues are the preferred uterotonic agents in patients with cardiovascular instability, while ergot derivatives should be avoided. 11

Continue hemodynamic monitoring for at least 24 hours after delivery to detect delayed complications such as pulmonary edema. 11